The ongoing clinical trial research report- “2019 Rheumatoid Arthritis Ongoing Clinical Trials Study” analyzes the current scenario of all active Rheumatoid Arthritis trials across the world. The report presents top level analysis of global Rheumatoid Arthritis clinical trials across countries, companies and universities. It is designed to provide clear understanding into the Rheumatoid Arthritis trials landscape to assist users for effective long term strategy formulation to beat competition.
The report covers a key snapshot of ongoing trial count, average enrollment per trial across countries.
It also segments the Rheumatoid Arthritis clinical trials by- • Region (Asia Pacific, Europe, Middle East Africa and Americas) • Countries • Trial Phase • Current Trial Status (Recruiting, Active, Planned, Active but Completed Recruiting, Not Yet Recruiting etc) • Type of the trial (Interventional, Observational) • Sponsor Type (Companies, Universities, Government Bodies etc) • Enrollment across types, sponsor types, geographies, current status and phases
The report also identifies the potential drug candidates under development for treatment of Rheumatoid Arthritis on the basis of intervention type ongoing Rheumatoid Arthritis trials.
The research work is prepared through extensive and continuous research on Rheumatoid Arthritis trials from over 150 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage: • All major ongoing trials from 2010 to 2019 and planned trials are included in the report scope. • Drug candidates currently being researched for administering Rheumatoid Arthritis patients are identified • The report includes panorama of ongoing Rheumatoid Arthritis clinical trials across the globe • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided • Companies and universities focusing on Rheumatoid Arthritis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status) • Average Enrollment number, insights into enrollment trends, company wise enrollment are included • Both interventional and observational studies are analyzed • News and latest developments for the past one year are presented in the report
Our reports have been used by over 10K customers, including:
Global Ibuprofen Market, By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations...
Europe specialty generics market reached a value of US$ 16.4 Billion in 2020. Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic...
KEY FINDINGS The Europe biosurgery market is predicted to record a CAGR of 6.16% during the forecasted years of 2021 to 2028. Factors such as the growing burden of chronic conditions likely to cause physical disability, the increasing adoption of new and advanced surgical products, as well as the rising number of surgeries...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the autoinjectors market are AbbVie, Mylan, Eli Lilly and Company, Amgen, Becton Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical, Merck, Pfizer, Bayer, Biogen, and AstraZeneca. The global autoinjectors market is expected to grow from $2.42 billion in 2020 to $2.94 billion in 2021 at a compound annual growth...
175 pages •
By The Business Research Company
• Aug 2021
Major players in the mobile imaging services market are Accurate Imaging Inc., Alliance HealthCare Services Inc., Axiom Mobile Imaging, Carestream Health, Center for Diagnostic Imaging Inc., Cobalt Health, DMS Health Technologies Inc., Front Range Mobile Imaging Inc., Imaging On Site Inc., InHealth Group Limited, Interim Diagnostic Imaging...
The global wearable injectors market is projected to reach USD 11.5billion by 2026 from USD 7.2billion in 2021, at a CAGR of 9.9% during the forecast period. Growth in this market is mainly driven by factors such as the shift of healthcare delivery toward homecare due to COVID-19, advantages of wearable injectors in the administration of various...
Endotracheal Tube Market Size, Share & Trends Analysis Report By Product Type (Regular Endotracheal Tube, Reinforced Endotracheal Tube), By Route Type, By Application, By End-use, By Region, And Segment Forecasts, 2021 - 2028
Endotracheal Tube Market Growth & Trends
The global endotracheal...
Global Rehabilitation Equipment Market, By Product Type (Daily Living Aid, Mobility Equipment, Walking Assist Devices, Exercise Equipment, Body Support Devices, Others), By Daily Living Aid (Medical Beds, Bathroom & Toilet Assist Devices, Reading & Writing Aids, Others), By Mobility Equipment (Mobility Scooters v/s Wheelchairs), By...
Surgical Retractors Market Size, Share & Trends Analysis Report By Type (Handheld, Self-retaining), By Product, By Application, By End-use (Hospitals, ASCs, Clinics), By Region, And Segment Forecasts, 2021 - 2028
Surgical Retractors Market Growth & Trends
The global surgical retractors market...
Chronic Disease Prevalence
Surgical Procedures Performed
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.